The same author also used this nanosystem to encapsulate rivastigmine, a reversible cholinesterase inhibitor used for the treatment of AD, and the results were in agreement with the latter-mentioned study; increasing brain uptake and reinforcing the capacity as a new drug carrier for AD [101]. This evidence concerns the gene BCHE and Alzheimer disease.